Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
Flux
Glenn
G
Bardies
Manuel
M
Chiesa
Carlo
C
Monsieurs
Myriam
M
Savolainen
Sauli
S
Strand
Sven-Erik
SE
Lassmann
Michael
M
D019797:3-Iodobenzylguanidine / Q000627:therapeutic use; D000818:Animals; D002986:Clinical Trials as Topic; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008223:Lymphoma / Q000532:radiotherapy*; D020714:Maximum Tolerated Dose; D018358:Neuroendocrine Tumors / Q000532:radiotherapy*; D010455:Peptides / Q000627:therapeutic use; D016499:Radioimmunotherapy / Q000379:methods; D011874:Radiometry / Q000379:methods*; D011878:Radiotherapy; D013964:Thyroid Neoplasms / Q000532:radiotherapy*
D007457:Iodine Radioisotopes; D010455:Peptides; D019797:3-Iodobenzylguanidine